Steinbrook R A, Freiberger D, Gosnell J L, Brooks D C
Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Anesth Analg. 1996 Nov;83(5):1081-3. doi: 10.1097/00000539-199611000-00032.
Two hundred adults undergoing laparoscopic cholecystectomy were enrolled in a prospectively randomized, double-blind investigation comparing ondansetron, 4 mg (Group O) with the combination of droperidol, 0.625 mg, and metoclopramide, 10 mg (Group DM). Antiemetic drugs were administered intravenously (IV) after induction of general anesthesia (propofol, desflurane). Moderate or severe nausea in the postanesthesia care unit was treated with the cross-over drug, i.e., ondansetron for patients in Group DM or droperidol plus metoclopramide for patients in Group O. Data were analyzed using t-tests and chi 2 analyses, with P < 0.05 considered statistically significant. The groups were similar with respect to gender, age, weight, duration of surgery, number receiving intraoperative atropine or ephedrine, number admitted over-night, and time to discharge home. Of 102 patients in Group O, 44 required antiemetics in the postanesthesia care unit, compared with 24 of 98 patients in Group DM (P < 0.01). One patient (in Group DM) was admitted for persistent nausea. In conclusion, droperidol 0.625 mg IV in combination with metoclopramide 10 mg IV was more effective in preventing postoperative nausea than was ondansetron 4 mg IV in patients undergoing laparoscopic cholecystectomy, with no difference in the time to discharge.
200例接受腹腔镜胆囊切除术的成年人参与了一项前瞻性随机双盲研究,该研究比较了4毫克昂丹司琼(O组)与0.625毫克氟哌利多和10毫克甲氧氯普胺的联合用药(DM组)。在全身麻醉诱导(丙泊酚、地氟醚)后静脉注射(IV)止吐药。麻醉后护理单元中出现中度或重度恶心的患者使用交叉用药进行治疗,即DM组患者使用昂丹司琼,O组患者使用氟哌利多加甲氧氯普胺。使用t检验和卡方分析对数据进行分析,P<0.05被认为具有统计学意义。两组在性别、年龄、体重、手术持续时间、术中接受阿托品或麻黄碱的人数、过夜住院人数以及出院回家时间方面相似。O组的102例患者中,有44例在麻醉后护理单元需要使用止吐药,而DM组的98例患者中有24例需要使用(P<0.01)。1例患者(DM组)因持续性恶心入院。总之,对于接受腹腔镜胆囊切除术的患者,静脉注射0.625毫克氟哌利多与10毫克静脉注射甲氧氯普胺联合用药在预防术后恶心方面比静脉注射4毫克昂丹司琼更有效,出院时间无差异。